Using transcriptional control to increase titers of secreted heterologous proteins by the type III secretion system

Applied and Environmental Microbiology

Volumn 80, Issue 19, 2014, Pages 5927-5934

  Metcalf, Kevin J ^a   Tullman Ercek , Danielle ^a   Azam , Anum ^a   Valdivia , Elias ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVITY; GENE ENCODING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES; PHYSIOLOGY; SALMONELLA; TRANSCRIPTION;

CULTURE SUPERNATANT; EXTRACELLULAR SPACE; HETEROLOGOUS PROTEIN PRODUCTION; HETEROLOGOUS PROTEINS; PROMOTER ACTIVITIES; SALMONELLA PATHOGENICITY ISLANDS; TRANSCRIPTIONAL CONTROL; TYPE III SECRETION SYSTEM;

PROTEINS;

BACTERIUM; ENZYME ACTIVITY; GENE; PATHOGENICITY; PROTEIN; SECRETION;

BACTERIAL PROTEIN; BETA LACTAMASE; HILA PROTEIN, SALMONELLA; SPI1 PROTEIN, SALMONELLA; TRANSACTIVATOR PROTEIN; TYPE III SECRETION SYSTEM;

GENE EXPRESSION REGULATION; GENETICS; GENOMIC ISLAND; METABOLISM; MULTIGENE FAMILY; PHYSIOLOGY; PROMOTER REGION; SALMONELLA ENTERICA; SECRETION (PROCESS); TRANSPORT AT THE CELLULAR LEVEL; TYPE III SECRETION SYSTEM;

BACTERIAL PROTEINS; BETA-LACTAMASES; BIOLOGICAL TRANSPORT; GENE EXPRESSION REGULATION, BACTERIAL; GENOMIC ISLANDS; MULTIGENE FAMILY; PROMOTER REGIONS, GENETIC; SALMONELLA ENTERICA; TRANS-ACTIVATORS; TYPE III SECRETION SYSTEMS;

EID: 84993906162     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01330-14     Document Type: Article

References (53)

1. Baneyx F. 1999. Recombinant protein expression in Escherichia coli. Curr. Opin.Biotechnol. 10:411-421. http://dx.doi.org/10.1016/S0958-1669(99) 00003-8.
2. Terpe K. 2006. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 72:211-222. http://dx.doi.org/10.1007/s00253-006-0465-8.
3. Miroux B, Walker JE. 1996. Overproduction of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J. Mol. Biol. 260:289-298. http://dx.doi.org/10.1006/jmbi.1996.0399.
4. Swartz JR. 2001. Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol. 12:195-201. http://dx.doi.org/10.1016/S0958-1669(00)00199-3.
5. Georgiou G, Segatori L. 2005. Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr. Opin. Biotechnol. 16:538-545. http://dx.doi.org/10.1016/j.copbio.2005.07.008.
6. Choi JH, Lee SY. 2004. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl. Microbiol. Biotechnol. 64: 625-635. http://dx.doi.org/10.1007/s00253-004-1559-9.
7. Hochkoeppler A. 2013. Expanding the landscape of recombinant protein production in Escherichia coli. Biotechnol. Lett. 35:1971-1981. http://dx.doi.org/10.1007/s10529-013-1396-y.
8. Gala´n JE, Collmer A. 1999. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284:1322-1328. http://dx.doi.org/10.1126/science.284.5418.1322.
9. Cornelis GR. 2006. The type III secretion injectisome. Nat. Rev. Microbiol. 4:811-825. http://dx.doi.org/10.1038/nrmicro1526.
10. Singer HM, Erhardt M, Steiner AM, Zhang M-M, Yoshikami D, Bulaj G, Olivera BM, Hughes KT. 2012. Selective purification of recombinant neuroactive peptides using the flagellar type III secretion system. mBio 3:e00115-12. http://dx.doi.org/10.1128/mBio.00115-12.
11. Schlumberger MC, Mu¨ller AJ, Ehrbar K, Winnen B, Duss I, Stecher B, Hardt W-D. 2005. Real-time imaging of type III secretion: Salmonella SipA injection into host cells. Proc. Natl. Acad. Sci. U. S. A. 102:12548- 12553. http://dx.doi.org/10.1073/pnas.0503407102.
12. Desvaux M, He´braud M, Henderson IR, Pallen MJ. 2006. Type III secretion: what's in a name? Trends Microbiol. 14:157-160. http://dx.doi.org/10.1016/j.tim.2006.02.009.
13. Widmaier DM, Tullman-Ercek D, Mirsky EA, Hill R, Govindarajan S, Minshull J, Voigt CA. 2009. Engineering the Salmonella type III secretion system to export spider silk monomers. Mol. Syst. Biol. 5:309. http://dx.doi.org/10.1038/msb.2009.62.
14. Majander K, Anton L, Antikainen J, La˚ng H, Brummer M, Korhonen TK, Westerlund-Wikstro¨m B. 2005. Extracellular secretion of polypeptides using a modified Escherichia coli flagellar secretion apparatus. Nat. Biotechnol. 23:475-481. http://dx.doi.org/10.1038/nbt1077.
15. Reference deleted
16. Widmaier DM, Voigt CA. 2010. Quantification of the physiochemical constraints on the export of spider silk proteins by Salmonella type III secretion. Microb. Cell Fact. 9:78. http://dx.doi.org/10.1186/1475-2859-9-78.
17. Tartera C, Metcalf ES. 1993. Osmolarity and growth phase overlap in regulation of Salmonella typhi adherence to and invasion of human intestinal cells. Infect. Immun. 61:3084-3089.
18. Lostroh CP, Lee CA. 2001. The Salmonella pathogenicity island-1 type III secretion system. Microbes Infect. 3:1281-1291. http://dx.doi.org/10.1016/S1286-4579(01)01488-5.
19. Sturm A, Heinemann M, Arnoldini M, Benecke A, Ackermann M, Benz M, Dormann J, Hardt W-D. 2011. The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1. PLoS Pathog. 7:e1002143. http://dx.doi.org/10.1371/journal.ppat.1002143.
20. Carleton HA, Lara-Tejero M, Liu X, Gala´n JE. 2013. Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery. Nat. Commun. 4:1590. http://dx.doi.org/10.1038/ncomms2594.
21. Lee CA, Jones BD, Falkow S. 1992. Identification of a Salmonella typhimurium invasion locus by selection for hyperinvasive mutants. Proc. Natl. Acad. Sci. U. S. A. 89:1847-1851. http://dx.doi.org/10.1073/pnas.89.5.1847.
22. Hoiseth SK, Stocker BAD. 1981. Aromatic-dependent Salmonella typhimurium are nonvirulent and effective as live vaccines. 291:238-239. http://dx.doi.org/10.1038/291238a0.
23. Temme K, Salis H, Tullman-Ercek D, Levskaya A, Hong S-H, Voigt CA. 2008. Induction and relaxation dynamics of the regulatory network controlling the type III secretion system encoded within Salmonella pathogenicity island 1. J. Mol. Biol. 377:47-61. http://dx.doi.org/10.1016/j.jmb.2007.12.044.
24. Lostroh CP, Lee CA. 2001. The HilA box and sequences outside it determine the magnitude of HilA-dependent activation of P prgH from Salmonella pathogenicity island 1. J. Bacteriol. 183:4876-4885. http://dx.doi.org/10.1128/JB.183.16.4876-4885.2001.
25. Lostroh CP, Bajaj V, Lee CA. 2000. The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI-1. Mol. Microbiol. 37:300-315. http://dx.doi.org/10.1046/j.1365-2958.2000.01991.x.
26. Lim S, Lee B, Kim M, Kim D, Yoon H, Yong K, Kang DH, Ryu S. 2012. Analysis of HilC/D-dependent invF promoter expression under different culture conditions. Microb. Pathog. 52:359-366. http://dx.doi.org/10.1016/j.micpath.2012.03.006.
27. Darwin KH, Miller VL. 2001. Type III secretion chaperone-dependent regulation: activation of virulence genes by SicA and InvF in Salmonella typhimurium. EMBO J. 20:1850-1862. http://dx.doi.org/10.1093/emboj/20.8.1850.
28. Cormack BP, Valdivia RH, Falkow S. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38. http://dx.doi.org/10.1016/0378-1119(95)00685-0.
29. Anderson JC, Dueber JE, Leguia M, Wu GC, Goler JA, Arkin AP, Keasling JD. 2010. BglBricks: a flexible standard for biological part assembly. J. Biol. Eng. 4:1-12. http://dx.doi.org/10.1186/1754-1611-4-1.
30. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
31. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. http://dx.doi.org/10.1038/227680a0.
32. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
33. Gassmann M, Grenacher B, Rohde B, Vogel J. 2009. Quantifying Western blots: pitfalls of densitometry. Electrophoresis 30:1845-1855. http://dx.doi.org/10.1002/elps.200800720.
34. Bajaj V, Hwang C, Lee CA. 1995. hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol. Microbiol. 18:715-727. http://dx.doi.org/10.1111/j.1365 -2958.1995.mmi_18040715.x.
35. Stebbins CE, Gala´n JE. 2001. Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion. Nature 414:77-81. http://dx.doi.org/10.1038/35102073.
36. Ahmad KF, Lim WA. 2010. The minimal autoinhibited unit of the guanine nucleotide exchange factor intersectin. PLoS One 5:e11291. http://dx.doi.org/10.1371/journal.pone.0011291.
37. Yeh BJ, Rutigliano RJ, Deb A, Bar-Sagi D, Lim WA. 2007. Rewiring cellular morphology pathways with synthetic guanine nucleotide exchange factors. Nature 447:596-600. http://dx.doi.org/10.1038/nature 05851.
38. Kimbrough TG, Miller SI. 2000. Contribution of Salmonella typhimurium type III secretion components to needle complex formation. Proc. Natl. Acad. Sci. U. S. A. 97:11008-11013. http://dx.doi.org/10.1073/pnas.200209497.
39. Bajaj V, Lucas RL, Hwang C, Lee CA. 1996. Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol. Microbiol. 22:703- 714. http://dx.doi.org/10.1046/j.1365-2958.1996.d01-1718.x.
40. Eichelberg K, Gala´n JE. 1999. Differential regulation of Salmonella typhimurium type III secreted proteins by pathogenicity island 1 (SPI-1)-encoded transcriptional activators InvF and HilA. Infect. Immun. 67: 4099-4105.
41. Raffatellu M, Sun Y-H, Wilson RP, Tran QT, Chessa D, Andrews-Polymenis HL, Lawhon SD, Figueiredo JF, Tsolis RM, Adams LG, Ba¨umler AJ. 2005. Host restriction of Salmonella enterica serotype Typhi is not caused by functional alteration of SipA, SopB, or SopD. Infect. Immun. 73:7817- 7826. http://dx.doi.org/10.1128/IAI.73.12.7817-7826.2005.
42. Radics J, Ko¨nigsmaier L, Marlovits TC. 2013. Structure of a pathogenic type 3 secretion system in action. Nat. Struct. Mol. Biol. 21:82-87. http://dx.doi.org/10.1038/nsmb.2722.
43. Wurm FM. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 22:1393-1398. http://dx.doi.org/10.1038/nbt1026.
44. Stader JA, Silhavy TJ. 1990. Engineering Escherichia coli to secrete heterologous gene products. Methods Enzymol. 185:166-187.
45. Schein CH. 1989. Production of soluble recombinant proteins in bacteria. Nat. Biotechnol. 7:1141-1149. http://dx.doi.org/10.1038/nbt1189-1141.
46. Schein CH. 1993. Solubility and secretability. Curr. Opin. Biotechnol. 4:456-461. http://dx.doi.org/10.1016/0958-1669(93)90012-L.
47. Heran Darwin K, Miller VL. 1999. InvF is required for expression of genes encoding proteins secreted by the SPI1 type III secretion apparatus in Salmonella typhimurium. J. Bacteriol. 181:4949-4954.
48. Moran U, Phillips R, Milo R. 2010. SnapShot: key numbers in biology. Cell 141:1262-1262. http://dx.doi.org/10.1016/j.cell.2010.06.019.
49. Hingorani KS, Gierasch LM. 2014. Comparing protein folding in vitro and in vivo: foldability meets the fitness challenge. Curr. Opin. Struct. Biol. 24:81-90. http://dx.doi.org/10.1016/j.sbi.2013.11.007.
50. Ellis RJ. 2001. Macromolecular crowding: obvious but underappreciated. Trends Biochem. Sci. 26:597-604. http://dx.doi.org/10.1016/S0968-0004 (01)01938-7.
51. Kadonaga JT, Gautier AE, Straus DR, Charles AD, Edge MD, Knowles JR. 1984. The role of the beta-lactamase signal sequence in the secretion of proteins by Escherichia coli. J. Biol. Chem. 259:2149-2154.
52. Driessen AJ, Fekkes P, van der Wolk JP. 1998. The Sec system. Curr. Opin. Microbiol. 1:216-222. http://dx.doi.org/10.1016/S1369-5274(98) 80014-3.
53. Wu¨lfing C, Plu¨ckthun A. 1994. Protein folding in the periplasm of Escherichia coli. Mol. Microbiol. 12:685-692. http://dx.doi.org/10.1111/j.1365 -2958.1994.tb01056.x.